AnalystsGavin Clark-GartnerGavin Clark-Gartner's Stock Forecasts
AnalystsGavin Clark-Gartner
Sectors:
Analyst Ranking
Bottom 5%
#5045 out of 5263 analysts
Average Return
-5.78%
Win Rate
39%16 out of 41
Risk vs Reward
Poor
Good
Gavin Clark-Gartner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Definium Therapeutics IncDFTX | +135.26% | $7.43 | $17.48 | 2025-01-28 - 2026-01-27 | Buy |
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-21 - 2024-12-20 | Buy |
Argenx SeARGX | +53.92% | $596.74 | $918.50 | 2024-11-21 - 2025-11-20 | Buy |
Mirum Pharmaceuticals IncMIRM | +52.56% | $59.97 | $91.49 | 2025-08-08 - 2026-04-24 | Buy |
Mirum Pharmaceuticals IncMIRM | +50.04% | $39.87 | $59.82 | 2024-08-08 - 2025-08-07 | Buy |
Gavin Clark-Gartner Analyst Color
Get additional color on Gavin Clark-Gartner's coverage of popular stocks
Gavin Clark-Gartner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Meiragtx Holdings PLCMGTX | 1 | Buy | $18.00 | +95.02% | Maintains | a month ago |
Jasper Therapeutics IncJSPR | 5 | Buy | $7.00 | +735.32% | Maintains | a month ago |
Damora Therapeutics IncDMRA | 1 | Buy | $46.00 | +85.86% | Initiates Coverage On | a month ago |
Mirum Pharmaceuticals IncMIRM | 5 | Buy | $126.00 | +37.72% | Maintains | 2 months ago |
Abbvie IncABBV | 6 | Buy | $228.00 | +14.74% | Maintains | 3 months ago |
Dyne Therapeutics IncDYN | 1 | Buy | $36.00 | +97.15% | Maintains | 4 months ago |
Vera Therapeutics IncVERA | 1 | Buy | $97.00 | +157.36% | Maintains | 5 months ago |
Evommune IncEVMN | 1 | Buy | $40.00 | +57.60% | Initiates Coverage On | 5 months ago |
Forte Biosciences IncFBRX | 1 | Buy | $65.00 | +136.79% | Initiates Coverage On | 5 months ago |
Argenx SeARGX | 5 | Buy | $910.00 | +16.63% | Maintains | 6 months ago |
Proqr Therapeutics NvPRQR | 1 | Buy | $5.00 | +222.58% | Initiates Coverage On | a year ago |
Definium Therapeutics IncDFTX | 1 | Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Cabaletta Bio IncCABA | 2 | Hold | $6.00 | N/A | Downgrades | a year ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $170.00 | N/A | Maintains | a year ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Krystal Biotech IncKRYS | 1 | Buy | $206.00 | N/A | Maintains | 2 years ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
C4 Therapeutics IncCCCC | 1 | Buy | $10.00 | N/A | Maintains | 3 years ago |
Inhibrx IncINBX1 | 1 | Buy | $60.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.